Epigral: Press Release on Un - Audited Financial Results – Q 2 FY 27
Epigral (EPIGRAL) filed a disclosure titled "Press Release on Un - Audited Financial Results – Q 2 FY 27". The company is valued at about ₹3,773 crore.
What happened
Epigral (EPIGRAL) filed a disclosure with the exchanges on 2 November 2026 at 01:59 PM titled "Press Release on Un - Audited Financial Results – Q 2 FY 27".
Company snapshot
Epigral is a small-cap company, with a market value of about ₹3,773 crore.
The stock last traded at ₹874.5, against a 52-week range of ₹807–₹1,709 (48.8% below the high).
Before this filing the shares had moved −14.1% over the month and −20.9% over three months. Average daily turnover over the last 20 sessions was about ₹3.84 crore.
Promoters held 68.83% at the end of Q1 FY27. Foreign institutions owned 1.03% and domestic institutions 5.56%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 607 | 160.7 | 37.25 |
| Q2 FY26 | 587 | 51.2 | 11.87 |
| Q3 FY26 | 597 | 39.1 | 9.07 |
| Q4 FY26 | 736 | 81 | 18.76 |
| Q1 FY27 | 705 | 99.7 | 23.12 |
What history shows
BCEIE's records show 4 previous results filings from the company since May 2026.
After those filings, the stock gained 0.7% on average the next trading day and was down 3.6% on average after five days (2 filings with price data).
Market-wide, 10,143 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 27 Jul 2026 | Board Meeting Outcome for Outcome Of Board Meeting Held On Monday,… | +0.7% | −3.6% |
| 27 Jul 2026 | UNAUDITED FINANCIAL RESULTS - 30.06.2026 | +0.7% | −3.6% |
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 2 November 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
- Epigral Ltd Gets Tax Assessment Order And Demand Notice For 281.1 Million Rupees
- Epigral (NSE:EPIGRAL): What Does Its Bank-Facility Rating Update Cover?
- Epigral Ltd Forms Death Cross, Signalling Potential Bearish Trend
- Epigral Limited: CRISIL Revises Credit Ratings to AA/Stable
- Epigral Limited reports Q2 and H1 FY27 unaudited financial results
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.